News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in Medicine
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement

Regulatory

Latest News

i1-152925-1408696002517.jpg
March 1st 2005
Global Report
By Sarah Houlton

Pharma companies in Europe believe that it already takes too long for new medicines to reach patients. Separate bodies for efficacy and safety will lead to further delays.

i1-152922-1408696009736.jpg
March 1st 2005

From the Editor

i1-153003-1408695933028.jpg
March 1st 2005

Washington Report: The Main Event Begins

By Jill Wechsler, Pharm Exec’s Washington Correspondent
i1-146581-1408696441583.jpg
February 1st 2005

Medicare: D Day

By Kevin Barnett
i1-146579-1408696446759.jpg
February 1st 2005

Side Effects

By Jill Wechsler, Pharm Exec’s Washington Correspondent
Advertisement

Advertisement
  • Prev
  • 1
  • More pages
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • Prev
Advertisement
Advertisement

Trending on PharmExec

1

Novo Nordisk Releases 2025 Financial Report and 2026 Sales and Operations Profit Outlook

2

Novartis’ Q4 Recap Shows Signs of Looming Patent Cliff

3

Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania

4

FDA Rejects AstraZeneca’s Application for Subcutaneous Indication of Saphnelo

5

From OR to Office: How Workflow Change and AI Are Reshaping MedTech Adoption

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us